You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vemurafenib

Showing 26 - 50 of 94
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Metastatic Trial in Guangzhou (Cetuximab, Irinotecan, Vemurafenib)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 7, 2021

Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +5 more
  • Jacksonville, Florida
  • +2 more
Oct 21, 2022

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

Malignant Melanoma Trial in France, Germany (Vemurafenib, Cobimetinib, Atezolizumab)

Terminated
  • Malignant Melanoma
  • Vemurafenib
  • +2 more
  • Marseille, France
  • +6 more
Jan 29, 2021

Melanoma Trial in Worldwide (Atezolizumab, Atezolizumab Placebo, Cobimetinib)

Active, not recruiting
Has Results
  • Melanoma
  • Birmingham, Alabama
  • +115 more
Jul 11, 2022

Advanced Malignant Tumor, BRAF Gene Mutation, Metastatic Malignant Tumor Trial in Houston (Crizotinib, Laboratory Biomarker

Completed
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2021

Melanoma Trial in New York (Vemurafenib)

Terminated
Has Results
  • Melanoma
  • Vemurafenib
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Sep 8, 2020

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Advanced Cancers Trial in Houston (Vemurafenib, Carboplatin, Paclitaxel)

Completed
  • Advanced Cancers
  • Vemurafenib
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 18, 2020

Cancer, Advanced Solid Tumors Trial in Amsterdam (Sunitinib, Sorafenib, Erlotinib)

Completed
  • Cancer
  • Advanced Solid Tumors
  • Amsterdam, Netherlands
    VUMedical Center
Apr 14, 2021

Malignant Melanoma Trial in United States (Atezolizumab, Cobimetinib, Vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +7 more
Jul 20, 2020

Advanced Cancer, Solid Tumor Trial in Houston (Vemurafenib, Everolimus, Temsirolimus)

Completed
  • Advanced Cancer
  • Solid Tumor
  • Vemurafenib
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 1, 2020

Metastatic Melanoma Trial in Copenhagen (Vemurafenib, Lymphodepleting chemo, TIL infusion)

Completed
Has Results
  • Metastatic Melanoma
  • Vemurafenib
  • +3 more
  • Copenhagen, Herlev, Denmark
    Center for Cancer Immune Therapy, Dept. of Haematology/Oncology
Mar 10, 2020

V600-mutated BRAF Unresectable Melanoma, V600-mutated BRAF Metastatic Melanoma, Stage III or Stage IV Metastatic Melanoma That

Terminated
Has Results
  • V600-mutated BRAF Unresectable Melanoma
  • +2 more
  • Los Angeles, California
  • +5 more
May 12, 2020

Langerhans Cell Histiocytosis Trial in Moscow (Vemurafenib, Cytarabine, 2-chlorodeoxyadenosine)

Unknown status
  • Langerhans Cell Histiocytosis
  • Vemurafenib
  • +2 more
  • Moscow, Russian Federation
    Dmitry Rogachev National Research Center of Pediatric Hematology
Apr 6, 2020

Tumors Trial in Worldwide (Vemurafenib)

Completed
Has Results
  • Neoplasms
  • Vemurafenib
  • Rogers, Arkansas
  • +82 more
Dec 11, 2020

NSCLC Trial in United States (Alectinib, Entrectinib, Vemurafenib)

Recruiting
  • Non-small Cell Lung Cancer
  • Duarte, California
  • +24 more
Feb 2, 2023

Breast Cancer, Gastrointestinal Cancer, Non Small Cell Lung Cancer Trial in Italy (Erlotinib, Trastuzumab, Trastuzumab

Recruiting
  • Breast Cancer
  • +3 more
  • Ancona, Italy
  • +40 more
Jan 25, 2023

Metastatic Cancer, Melanoma Trial run by the NCI (Vemurafenib, Young TIL, Cyclophosphamide)

Terminated
  • Metastatic Cancer
  • Melanoma
  • Vemurafenib
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 20, 2019

Metastatic Melanoma, BRAF V600 Mutation Positive Trial in Worldwide (Itraconazole, Rifampin, Vemurafenib)

Completed
  • Metastatic Melanoma, BRAF V600 Mutation Positive
  • Dallas, Texas
  • +10 more
Feb 11, 2020

Relapsed Pediatric Solid Tumor, Refractory Pediatric Solid Tumor, Relapsed Pediatric AML Trial in Seoul (CancerSCAN™,

Recruiting
  • Relapsed Pediatric Solid Tumor
  • +3 more
  • CancerSCAN™
  • +17 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 18, 2020

Malignant Melanoma Trial in Worldwide (Placebo, Vemurafenib, Cobimetinib)

Completed
Has Results
  • Malignant Melanoma
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +155 more
Sep 14, 2020

Malignant Melanoma Trial in Beijing, Guangzhou (Vemurafenib)

Completed
Has Results
  • Malignant Melanoma
  • Vemurafenib
  • Beijing, China
  • +1 more
May 26, 2019

Malignant Melanoma Trial in Australia, United States (Cobimetinib, vemurafenib)

Completed
Has Results
  • Malignant Melanoma
  • Los Angeles, California
  • +9 more
Jul 26, 2019

Melanoma Trial in Worldwide (Dabrafenib, Vemurafenib, Trametinib)

Completed
Has Results
  • Melanoma
  • Birmingham, Alabama
  • +204 more
Feb 8, 2021